BioSpace News Archive

Business

Coeptis Combines with Bull Horn in SPAC Deal to Advance CD38+ Assets

Coeptis Therapeutics is merging with special purpose acquisition company Bull Horn Holdings in a definitive deal worth around $175 million.

April 20, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Money on the Move: Tessera, Unlearn.AI, Blue Spark, Alzheon and Trevana

The major money winners this week included a DNA editing platform, a machine-learning platform that creates digital patient “twins” and wearable temperature-monitoring patches.

April 20, 2022
·
3 min read
·
Hannah Chudleigh
Business

Joseph Romanelli Returns to Merck as Head of Human Health International Division

After a stint as head of a pharmaceutical company in China, Joseph Romanelli is returning to Merck as head of the human health international division.

April 20, 2022
·
2 min read
·
Alex Keown
Policy

Illumina Chief: “The Goal Should Be This Is Our Last Pandemic”

More than two years into the COVID-19 pandemic, some experts, business leaders and government agencies are starting to prep for the next potential pandemic.

April 20, 2022
·
5 min read
·
Mark Terry
Business

Former Novartis Exec Helms Newly Launched Satellite Bio

The company brings to the arena bioengineered tissues that repair, restore or replace an organ or tissue functioning, called Tissue Therapeutics.

April 20, 2022
·
2 min read
·
Hayley Shasteen
Policy

Gilead Secures Legal Victory in Battle Against HIV Drug Fraud

Gilead Sciences scored a legal victory regarding fraudulent HIV reimbursements, securing a court order against a number of clinics, labs and prescribers in Florida that were engaging in the alleged fraud.

April 20, 2022
·
3 min read
·
Alex Keown
Drug Development

AlloVir Snags Coveted RMAT Designation For T Cell Therapy

RMAT designation means a faster, more streamlined approval process and frequent communication with FDA representatives. The FDA recently granted RMAT Designations to both Direct Bio and AlloVir.

April 20, 2022
·
3 min read
·
Hannah Chudleigh
GSK-Backed Researchers Bring New Meaning to Lupus Disease Modification

Proposing a standardized definition of what disease modification looks like in SLE and LN that can drive outcomes measured in clinical trials, is an important step.

April 20, 2022
·
6 min read
·
Hayley Shasteen
Cleanroom Consumables Market Analysis and Forecast by 2031

Albany NY, United States: The global cleanroom consumables market was valued over US$ 16.4 Bn in 2020 and is projected to expand at a CAGR of 0.4% from 2021 to 2031.

April 20, 2022
·
5 min read
Digital Pathology Market: Diagnostic Laboratories Segment Hold a Major Share of the Market

Albany NY, United States: Transparency Market Research has published a new report titled, ‘Digital Pathology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

April 20, 2022
·
7 min read